Viewing StudyNCT06656624



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06656624
Status: RECRUITING
Last Update Posted: None
First Post: 2024-10-23

Brief Title: Efficacy and Safety of Ribociclib Combined With AI Versus PhysicianAmp39s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expressionHER2-negative Advanced Breast Cancer Rachel
Sponsor: None
Organization: None

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2024-10-23
First Submit QC Date: None
Study First Post Date: None
Study First Post Date Type: None
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-23
Last Update Post Date: None
Last Update Post Date Type: None